Clinical Development

(elenabs/iStock via Getty Images Plus)

Latest FDA COVID-19 updates

By Jenni Spinner

The federal agency continues to offer advice and take actions related to COVID-19, impacting drug development, clinical trials and other activities.

(zubada/iStock via Getty Images Plus)

This week’s FDA COVID-19 updates

By Jenni Spinner

The agency continues to offer advice and take actions impacting the pharmaceutical and life-science industries during the pandemic.

(Image: Getty/wildpixel)

Immunai unveils map of human immune system

By Jenni Spinner

A research team including MIT, Harvard and Stanford researchers has raised $20m in seed funding for their effort to map out immune cells with machine learning.

(Image: Getty/gorodenkoff)

Avalere: FDA can impact COVID-era drug development

By Jenni Spinner

A representative of the life-sciences consulting firm outlines how the federal agency has reacted to the COVID-19 pandemic, and how it might advise the industry going forward.

Follow us

Products

View more

Webinars